Trieu Vuong bought OTLC

July 8, 2025 · Form 4 insider transaction

Trieu Vuong bought 94,736 shares of Oncotelic Therapeutics, Inc. at $0.01 per share, a transaction worth $473.68. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.